Dr Richard Makurumidze

Qualifications: MBChB (UZ), MPhil (Stellenbosch), MPH (UZ), Dip HIV Man (Colleges of Medicines SA), PhD Medical Sciences (Vrije Universiteit Brussels)

Bio: 

Specialist Public Health Physician with over 10 years of experience in clinical medicine, health programmes implementation, evaluation, teaching and research. He has worked in HIV & TB programme implementation with the following organisations; Population Services International, Global Fund, MSF and PEPFAR supported International Training Education and Centre for Health before joining the University of Zimbabwe. He is (has been) involved in various educational, training and capacity building initiatives which include the Short Course in Antiretroviral Therapy at the Institute of Tropical Medicine in Antwerp, Belgium; and the Zimbabwe Ministry of Health and Child Care National HIV, TB & STI Mentorship and Capacity Building Programme. At the University of Zimbabwe, he teaches epidemiology, research, communicable and non-communicable diseases to undergraduates and postgraduates students. He is also involved is the supervision of postgraduate research projects for Masters and PhD students.

His PhD was a sandwich programme between the University of Zimbabwe, the Institute of Tropical Medicine in Antwerp and Vrije Universiteit Brussels, Belgium. He was awarded a scholarship funded by the Belgian Development Cooperation. His PhD project focused on the implementation of HIV Treat All in Zimbabwe. He currently has a Post–Doctoral Scholarship at the University of Zimbabwe funded by the National Institutes of Health (NIH) through the Enhancing NCDs Research and Innovation Capacity in Harare (ENRICH) program aimed at addressing the burden of NCDs in Zimbabwe, as an emerging major cause of morbidity and mortality in SSA.

Research interests: HIV, Tuberculosis, COVID-19, Non-communicable diseases, Maternal and child health

Email: This email address is being protected from spambots. You need JavaScript enabled to view it.

Phone number: +263772759296

Publications:

1. Park, Seung Hyun ; Hong, Sung Hwi ; Kim, Kwanghyun ; Lee, Seung Won ; Yon, Dong Keon ; Jung, Sun Jae ; Abdeen, Ziad ; Brahim Ahmed, Mohamed Lemine Cheikh ; Serouri, Abdulwahed Al ; Al-Herz, Waleed ; Subbaram, Kannan ; Shaik Syed, P ; Ali, Sheeza ; Ali, Kosar ; Al-Shamsi, Humaid O ; Baatarkhuu, Oidov ; Nielsen, Henning Bay ; Bernini-Carri, Enrico ; Bondarenko, Anastasiia ; Cassell, Ayun ; Cham, Akway ; Chua, Melvin Lk ; Dadabhai, Sufia ; Darre, Tchin ; Davtyan, Hayk ; Dragioti, Elena ; East, Barbora ; Jeffrey Edwards, R ; Ferioli, Martina ; Georgiev, Tsvetoslav ; Ghandour, Lilian ; Harapan, Harapan ; Hsueh, Po-Ren ; Ikram, Aamer ; Inoue, Shigeru ; Jacob, Louis ; Janković, Slobodan ; Jayarajah, Umesh ; Jesenak, Milos ; Kakodkar, Pramath ; Kapata, Nathan ; Kebede, Yohannes ; Khader, Yousef ; Kifle, Meron ; Koh, David ; Maleš, Višnja Kokić ; Kotfis, Katarzyna ; Koyanagi, Ai ; Kretchy, James-Paul ; Lakoh, Sulaiman ; Lee, Jinhee ; Lee, Jun Young ; Mendonça, Maria da Luz Lima ; Ling, Lowell ; Llibre-Guerra, Jorge ; Machida, Masaki ; Makurumidze, Richard ; Mallah, Saad ; Memish, Ziad A ; Mendoza, Ivan ; Moiseev, Sergey ; Nadasdy, Thomas ; Nahshon, Chen ; Ñamendys-Silva, Silvio A ; Yongsi, Blaise Nguendo ; Nicolasora, Amalea Dulcene ; Nugmanova, Zhamilya ; Oh, Hans ; Oksanen, Atte ; Owopetu, Oluwatomi ; Ozguler, Zeynep Ozge ; Perez, Gonzalo Emanuel ; Pongpirul, Krit ; Rademaker, Marius ; Radojevic, Nemanja ; Roca, Anna ; Rodriguez-Morales, Alfonso J ; Viveiros Rosa, Sandro G ; Roshi, Enver ; Saeed, Khwaja Mir Islam ; Sah, Ranjit ; Sakakushev, Boris ; Sallam, Dina Ebrahem ; Sathian, Brijesh ; Schober, Patrick ; Simonović, Zoran ; Singhal, Tanu ; Skhvitaridze, Natia ; Solmi, Marco ; Tizaoui, Kalthoum ; Tlhakanelo, John Thato ; Torales, Julio ; Torres-Roman, Smith ; Tsartsalis, Dimitrios ; Tsolmon, Jadamba ; Vieira, Duarte Nuno ; Wanghi, Guy ; Wollina, Uwe ; Xu, Ren-He ; Yang, Lin ; Zia, Kashif ; Zildzic, Muharem ; Il Shin, Jae ; Smith, Lee. / Non-Pharmaceutical Interventions Reduce the Incidence, and Mortality of COVID-19 : A Study based on the Survey from the International COVID-19 Research Network (ICRN). In: Journal of Medical Virology. 2022. https://doi.org/10.1002/jmv.28354
2. Abou Ghayda, Ramy ; Lee, Keum Hwa ; Han, Young Joo ; Ryu, Seohyun ; Hong, Sung Hwi ; Yoon, Sojung ; Jeong, Gwang Hum ; Yang, Jae Won ; Lee, Hyo Jeong ; Lee, Jinhee ; Lee, Jun Young ; Effenberger, Maria ; Eisenhut, Michael ; Kronbichler, Andreas ; Solmi, Marco ; Li, Han ; Jacob, Louis ; Koyanagi, Ai ; Radua, Joaquim ; Park, Myung Bae ; Aghayeva, Sevda ; Ahmed, Mohamed L C B ; Al Serouri, Abdulwahed ; Al-Shamsi, Humaid O ; Amir-Behghadami, Mehrdad ; Baatarkhuu, Oidov ; Bashour, Hyam ; Bondarenko, Anastasiia ; Camacho-Ortiz, Adrian ; Castro, Franz ; Cox, Horace ; Davtyan, Hayk ; Douglas, Kirk ; Dragioti, Elena ; Ebrahim, Shahul ; Ferioli, Martina ; Harapan, Harapan ; Mallah, Saad I ; Ikram, Aamer ; Inoue, Shigeru ; Jankovic, Slobodan ; Jayarajah, Umesh ; Jesenak, Milos ; Kakodkar, Pramath ; Kebede, Yohannes ; Kifle, Meron ; Koh, David ; Males, Visnja K ; Kotfis, Katarzyna ; Lakoh, Sulaiman ; Ling, Lowell ; Llibre-Guerra, Jorge ; Machida, Masaki ; Makurumidze, Richard ; Mamun, Mohammed A ; Masic, Izet ; Van Minh, Hoang ; Moiseev, Sergey ; Nadasdy, Thomas ; Nahshon, Chen ; Ñamendys-Silva, Silvio A ; Yongsi, Blaise N ; Nielsen, Henning B ; Nodjikouambaye, Zita A ; Ohnmar, Ohnmar ; Oksanen, Atte ; Owopetu, Oluwatomi ; Parperis, Konstantinos ; Perez, Gonzalo E ; Pongpirul, Krit ; Rademaker, Marius ; Rosa, Sandro ; Sah, Ranjit ; Sallam, Dina ; Schober, Patrick ; Singhal, Tanu ; Tafaj, Silva ; Torres, Irene ; Torres-Roman, J Smith ; Tsartsalis, Dimitrios ; Tsolmon, Jadamba ; Tuychiev, Laziz ; Vukcevic, Batric ; Wanghi, Guy ; Wollina, Uwe ; Xu, Ren-He ; Yang, Lin ; Zaidi, Zoubida ; Smith, Lee ; Shin, Jae Il. / The global case fatality rate of coronavirus disease 2019 by continents and national income : A meta-analysis. In: Journal of Medical Virology. 2022 ; Vol. 94, No. 6. pp. 2402-2413. https://doi:10.1002/jmv.27610 
3. Trudy Tholakele Mhlanga, Bart Karl Jacobs , Tom Decroo, Wim Van Damme, Simbarashe Rusakaniko Lutgarde Lynen, Richard Makurumidze. Virological outcomes and risk factors for non-suppression for routine and repeat viral load testing after enhanced adherence counselling during viral load testing scale-up in Zimbabwe: analytic cross-sectional study using laboratory data from 2014 to 2018. AIDS research and therapy. 2022 Jul 9;19(1). 34. https://doi.org/10.1186/s12981-022-00458-z
4. Makurumidze R. Experiences and Lessons Learnt from the HIV Treat All Pilot Phase Implementation in Zimbabwe. HIV AIDS (Auckl). 2021;13:823-828
5. Richard Makurumidze, Jozefien Buyze, Tom Decroo, Lutgarde Lynen, James Hakim, Wim Van Damme, Simbarashe Rusakaniko et al. Patient and programmatic characteristics, retention and predictors of attrition among patients starting antiretroviral therapy (ART) before and after the implementation of HIV Treat All in Zimbabwe https://doi.org/10.1101/2020.07.12.20151845
6. Makurumidze, R., Gombe, N.T., Magure, T. et al. Investigation of an anthrax outbreak in Makoni District, Zimbabwe. BMC Public Health 21, 298 (2021). https://doi.org/10.1186/s12889-021-10275-0
7. Makurumidze, R., Decroo, T., Lynen, L. et al. District-level strategies to control the HIV epidemic in Zimbabwe: a practical example of precision public health. BMC Res Notes 13, 393 (2020). https://doi.org/10.1186/s13104-020-05234-8
8. Richard Makurumidze et al. Assessment of the transport management systems for National Acquired Immunodeficiency Syndrome (AIDS) Council of Zimbabwe Global Fund Round 8 grant sub-recipients and implementing partners, 2014. Pan African Medical Journal. 2020; 37:226. [doi: 11604/pamj.2020.37.226.21202]
9. Grant Murewanhema, Richard Makurumidze. Essential health services  delivery  in  Zimbabwe  during  the  COVID-19 pandemic: perspectives and recommendations. Pan African Medical Journal. 2020;35(2):143. 10.11604/pamj.supp.2020.35.143.25367
10. Richard Makurumidze. Coronavirus-19 disease (COVID-19): A case series of early suspected cases reported and the implications towards the response to the pandemic in Zimbabwe. https://doi.org/10.1016/j.jmii.2020.04.002
11. Richard Makurumidze. Empathy and use of evidence in handling travellers coming from COVID-19 high-risk countries. Pan African Medical Journal. 2020;35(2):60. https://doi.org/10.11604/pamj.2020.35.2.23859
12. Makurumidze R, Mutasa-Apollo T, Decroo T, Choto RC, Takarinda KC, Dzangare J, et al. (2020) Retention and predictors of attrition among patients who started antiretroviral therapy in Zimbabwe’s national antiretroviral therapy programme between 2012 and 2015. PLoS ONE 15(1): e0222309. https://org/10.1371/journal.pone.0222309
13. Richard Makurumidze, Notion Gombe, Donewell Bangure, Lucia Takundwa, Cremance Tshuma, Tapiwa Magure and Mufuta Tshimanga Evaluation of the Tuberculosis Surveillance System in Shamva District 2014. Journal of US-China Medical Science 14 (2017) 64-7.  https://doi:10.17265/1548-6648/2017.02.003  
14. Makurumidze R, Bangure D, Tshimanga M, Takundwa L, Chinamasa C, Magure T. Factors associated with Occupational Injuries at a Mine. Journal of Science in Southern Africa Volume 19 Issue II; February 2015. University of Zimbabwe Publications. https://doi:10.6084/m9.figshare.11636856
15. Richard Makurumidze. Retention and viral suppression among patients on ART before and after the implementation of the HIV “Treat All” guidelines in Zimbabwe. Book ISBN: 9789461174413 VUB Press, Brussels, Belgium Available at: https://researchportal.vub.be/en/publications/retention-and-viral-suppression-among-patients-on-antiretroviral-  
16. Mundagowa PT, Tozivepi SN, Chiyaka ET, Mukora-Mutseyekwa F, Makurumidze R. Assessment of COVID-19 vaccine hesitancy among Zimbabweans: A rapid national survey. PLoS One. 2022;17: 1–17. https://doi:10.1371/journal.pone.0266724
17. Murewanhema G, Musuka G, Gwanzura C, Makurumidze R, Chitungo I, Chimene M, et al. Maternal, Sexual and Reproductive Health in Marginalised Areas: Renewing Community Involvement Strategies beyond the Worst of the COVID-19 Pandemic. Int J Environ Res Public Health. 2022;19: 3431. https://doi:10.3390/ijerph19063431
18. Richard Makurumidze; Mutsa Mhangara ; Justice Mudavanhu ; Grant Murewanhema. Gaps and recommendations on the management of the coronavirus disease 2019 (COVID-19) in the Zimbabwean quarantine centres during the first wave (March – October 2020) Journal of Interventional Epidemiology and Public Health. 2023;6(1):6. https://doi:10.11604/JIEPH.supp.2023.6.1.1213
19. Manes Munyanyi, Richard Makurumidze, Patron Mafaune, Winston Chirombe, National and subnational coverage and other service statistics for reproductive, maternal, newborn and child health from health facility data and surveys in Zimbabwe, 2022, https://www.countdown2030.org/wp-content/uploads/2023/02/Overall-Country-Report-Zimbabwe_Final_080822.pdf
20. Makurumidze, R., Decroo, T., Jacobs, B.K.M. et al. Attrition one year after starting antiretroviral therapy before and after the programmatic implementation of HIV “Treat All” in Sub-Saharan Africa: a systematic review and meta-analysis. BMC Infect Dis 23, 558 (2023). https://doi.org/10.1186/s12879-023-08551-y

Professor

Prof J.G. Hakim

MBChB, MMed, MSC, FRCP (Lond & Edin)                 

E-mail : This email address is being protected from spambots. You need JavaScript enabled to view it.

Publications: 

Robertson K, Jiang H, Kumwenda J, Supparatpninyo K, Evans S, Campbell TB, Price R, Tripathy S, Kumarasamy N, La Rosa A, Santos B: the 5199 study team, Silva MT, Montano S, Kanyama C, Faesen S, Murphy R, Hall C, Marra CM, Marcus C, Berzins B, Allen R, Housseinipour M, Amod F, Sanne I, Hakim J, Walawander A, Nair A; the AIDS Clinical Trials Group. Improved Neuropsychological and Neurological Functioning Across Three Antiretroviral Regimens in Diverse Resource-Limited Settings: AIDS Clinical Trials Group Studay A5199, the International Neurological Study. Clin Infect Dis. 2012: 55:868-876

Medina Lara A, Kigozi, Amurwon J, Muchabaiwa L, Nyanzi Wakaholi B, Mujica Mota RE, Walker AS, Kasirye R, Ssali F, Reid A, Grosskuth H, Babiker AG, Kityo C, Katabira E, Munderi P, Mugyenyi P, Hakim J, Darbyshire J, Gibb DM, Gilks CF; DART Trial Team. Cost effectiveness analysis of clinically driven versus routine laboratory monitoring of antiretroviral therapy in Uganda and Zimbabwe. PLoS One 2012; 7(4):e33672.

Kiwuwa-Muyingo S, Walker AS, Oja H, Levin J, Miiro G, Katabira E, Kityo C, Hakim J, Todd J; the DART Trial Team. The impact of first year adherence to antiretroviral therapy on long-term clinical and immunological outcomes in the DART trial in Uganda andTrop Med Int Health. 2012 March 30. Doi: 10.1111/j.1365-3156. 2012.02974 .x.

Kuritzkes D.R, Hakim J.G, Sanne I. Least among equals. Clin Infect Disease. 2012; 54: 876-7

Campbell TB, Smeaton LM, Kumarasamy N, Flanigan T, Klingman KL, Firnhaber C, Grinsztejn B, Hosseinipour MC, Kumwenda J, Lalloo U, Riviere C, Sanchez J, Melo M, Supparatpinyo K, Tripathy S, Martinz Al, Nair A, Walawander A, Moran L, Chen Y, Snowden W, Rooney JF, Uy J, Schooley RT, De Gruttola V, Hakim JG; PEARLS study team to the ACTG. Efficacy and Safety of Three Antiretroviral Regiments for Initial Treatment of HIV-1: A randomized Clinical Trial in Diverse Multinational Settings,. PLoS Med. 2012 (8): e1001290.

Gibb DM, Kizito H, Russel EC, Chidziva E, Zalwango E, Nalumenya R, Spyer M, Tumukunde D, Nathoo K, Mundeti P, Kyomugisha H, Hakim J, Grosskurth H, Gilks CF, Walker AS, Musoke P; DART trial team. Pregnancy and infant outcomes among HIV-Infercted women taking long term ART with and without tenofovir in the DART trial. PLoS Med. 2012;9 (5): e1001217

Stohr W, Reid A, Walker AS, Ssali F, Munderi P, Mambule I, Kityo C, Grosskurth H, Gilks CF, GibbDM, Hakim J; DART Trial Team. Glomerular dysfunction and associated risk factors over 4-5 years following antiretroviral therapy initiation in Africa. Antivir Ther. 2011;16:1011-20

Havlir DV, Kendall MA, Ive P, Kumwenda J, Swindells, Qasba SS Luetmemeyer AF, Hogg E, Rooney JF, Wu X, Hosseinipour MC, Lalloo U, Veloso VG, Some FF, Kumarasamy N, Padayatchi N, Santos BR, Reid S, Hakim J, Mohapi L, Mugyenyi P, Sanchez J, Lama JR, Pape JW, Sanchez A, Asmelash A, Moko E, Sawe F, Andersen J, Sanne I; AIDS Clinical Trials Group Study A5221. Timing of antiretroviral therapy for HIV-1 infection and tuberculosis. N ENGL J Med. 2011;365:

Robertson K, Kumwenda J, Supparatpinyo K, Jiang JH, Evans S, Campbel TB, Price RW, Murphy R, Hall C, Marra CM, Marcus C, Berzins B, Masih R, Santos B, Silva MT, Kumarasamy N, Walawander A, Nair A, Tripathy S, Kanyama C, Hosseinipour M, Montano S, La Rosa A, Amond F, Sanne I, Firnhaber C, Hakim J, Brouwers P, AIDS Clinical Trials Group. A multinational study of neurological performance in antiretroviral therapy-naive HIV-1 infected persons in diverse resource-constrained settings. J Neurovirol. 2011;17:438-47

Sibanda EL, Weller IV, Hakim JG, Cowan FM. Does trimethoprim-sulfamethoxazole prophylaxis for HIV induce bacterial resistance to other antibiotic classes? Results of a systematic review. Clin Infect Dis.2011;52:1184-94

Hakim J.G, Matenga J.A, Havranek E, Kao D, Health Workforce development with a focus on cardiovascular disease in Zimbabwe; CHRIS Program, a medical education partnership initiative. Global Heart 2011;6 (4)219-220.

Cohen MS, Chen YQ, McCauley M, Gamble T, Hosseinipour MC, Kumarasamy N, Hakim J.G, Kumwenda J, Grinsztejn B, Pilotto JHS, Godbole SV, Mehendale S, Chariyalertsak S, Santos BR, Mayer KH, Hoffman IFP, Elshleman SH, Piwowar-Manning E, Wang L, Makhema J, Mills LA, de Bruyn G, Sanne I, Eron J, Gallant J, Havlir D, Swindells S, Rivaudo H, Elharrar V, Burns D, Taha TE, Nielsen-Saines K, Celentano D, Essex M, Flemming TR, for the HPTN 052 Study Team. Prevention of HIV-1 Infection with Early antiretroviral therapy. N Engl J Med. 2011; 365:493-505.

Grinsztejn B, Smeaton L, Barnett R, Klingman K, Hakim J, Flanigan T, Kuramarasamy N, Campbell T, Currier J, PEARLS study team of the ACTG. Sex-associated differences in pre-antiretroviral therapy plasma HIV-1 RNA in diverse areas of the world vary by CD4 (+) T-Cell count. Antivir Ther. 2011; 16:1057-62

Havlir DV, Kendall M.A, Ive P, Kumwenda J, Swindells S, Qasba SS, Luetkemeyer AF, Hoff E, Rooney JF, Wu X, Hosseinipour MC, Lallo U, Veloso VG, Some FF, Kumarasamy N, Padayatchi N, Santos BR, Reid S, Hakim J, Mohapi L, Mugyenyi P, Sanchez J, Lama JR, Pape JW, Sanchez A, Asmelash A, Moko E, Sawe R, Andersen J, Sanne I; AIDS Clinical Trials Group Study A5221. Timing of ART therapy for HIV-1 infection and tuberculosis. N Engl J Med. 2011; 365:1482-91

Eshleman SH, Hudelson SE, Redd AD, Wang L, Debes R,Chen YQ, Martens CA, Ricklefs SM, Selig EJ, Porcella SF, Munshaw S, Ray SC, Piwowar-Minning E, McCauley M, Hosseinipour MC, Kumwenda J, Hakim J, Chariyalertsak S, de Bruyn G, Grinsztejn B, Kumarasamy N, Makhema J, Mayer KH, PilottoJ, Santos BR, Quinn TC, Cohen MS, Hughes JP. Analysis of genetic linkage of HIV from couples enrolled in the HPTN 052 trial. J Infect Dis. 2011; 204:1918-26

Campbel TB, Smeaton LM, Kumarasamy N, FlaniganT, KlingmanKL, FirnhaberC, Grinsztejn B, Hosseinpour MC, Kumwenda J, Lallo U, Riviere C, Sanchez J, Melo M, Supparatpinyo K, Tripathy S, Martinez Al, Nair A, Walawander A, Moran L, Chen Y, Snowden W, Rooney JF, Uy J, Schooley RT, De Gruttola V, Hakim J.G; PEARLS study team of the ACTG. Efficacy and Safety of three antiretroviral Regimens for Initial Treatment of HIV-1: A Randomised Clinical Trial in Diverse Multinational Settings. PLoS Med. 2012 (8):e 1001290.

Gibb DM, Kizito H, Russell EC, Chidziva E, Zalwango E, Nalumenya R, Spyer M, Tumukunde D, Nathoo K, Munderi P, Kyomugisha H, Hakim J, Grosskurth H, Gilks CF, Walker AS, Musoke P; DART trial team. Pregnancy and infant outcomes among HIV-infected woman taking long-term ART with and without tenofovir in the DART trial. PLoS Med. 2012; 9(5):e1001217.